Literature DB >> 12874367

Molecular characterization of the sucB gene encoding the immunogenic dihydrolipoamide succinyltransferase protein of Bartonella vinsonii subsp. berkhoffii and Bartonella quintana.

Robert D Gilmore1, Amber M Carpio, Michael Y Kosoy, Kenneth L Gage.   

Abstract

Members of the genus Bartonella have historically been connected with human disease, such as cat scratch disease, trench fever, and Carrion's disease, and recently have been recognized as emerging pathogens causing other clinical manifestations in humans. However, because little is known about the antigens that elicit antibody production in response to Bartonella infections, this project was undertaken to identify and molecularly characterize these immunogens. Immunologic screening of a Bartonella vinsonii subsp. berkhoffii genomic expression library with anti-Bartonella antibodies led to the identification of the sucB gene, which encodes the enzyme dihydrolipoamide succinyltransferase. Antiserum from a mouse experimentally infected with live Bartonella was reactive against recombinant SucB, indicating the mounting of an anti-SucB response following infection. Antigenic cross-reactivity was observed with antiserum against other Bartonella spp. Antibodies against Coxiella burnetti, Francisella tularensis, and Rickettsia typhi also reacted with our recombinant Bartonella SucB. Potential SucB antigenic cross-reactivity presents a challenge to the development of serodiagnostic tests for other intracellular pathogens that cause diseases such as Q fever, rickettsioses, brucelloses, tularemia, and other bartonelloses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874367      PMCID: PMC166034          DOI: 10.1128/IAI.71.8.4818-4822.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Cloning, nucleotide sequence, and expression of the Brucella melitensis sucB gene coding for an immunogenic dihydrolipoamide succinyltransferase homologous protein.

Authors:  M S Zygmunt; M A Díaz; A P Teixeira-Gomes; A Cloeckaert
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Production of Bartonella genus-specific monoclonal antibodies.

Authors:  Z Liang; B La Scola; H Lepidi; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

3.  Bartonella vinsonii subsp. berkhoffii as an agent of afebrile blood culture-negative endocarditis in a human.

Authors:  V Roux; S J Eykyn; S Wyllie; D Raoult
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Species-specific monoclonal antibodies for rapid identification of Bartonella quintana.

Authors:  Z Liang; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

5.  Transcription analysis of the sucAB, aceEF and lpd genes of Escherichia coli.

Authors:  M E Spencer; J R Guest
Journal:  Mol Gen Genet       Date:  1985

6.  Demonstration of Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis.

Authors:  F T Kerkhoff; A M Bergmans; A van Der Zee; A Rothova
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

7.  Differentiation of Bartonella species by a microimmunofluorescence assay, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Western immunoblotting.

Authors:  Z Liang; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 8.  Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection.

Authors:  E B Breitschwerdt; D L Kordick
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

9.  Coyotes (Canis latrans) as the reservoir for a human pathogenic Bartonella sp.: molecular epidemiology of Bartonella vinsonii subsp. berkhoffii infection in coyotes from central coastal California.

Authors:  C C Chang; R W Kasten; B B Chomel; D C Simpson; C M Hew; D L Kordick; R Heller; Y Piemont; E B Breitschwerdt
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

10.  Molecular evidence of Bartonella spp. in questing adult Ixodes pacificus ticks in California.

Authors:  C C Chang; B B Chomel; R W Kasten; V Romano; N Tietze
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

View more
  7 in total

1.  Proteomic and immunoblot analyses of Bartonella quintana total membrane proteins identify antigens recognized by sera from infected patients.

Authors:  Jenni K Boonjakuakul; Helen L Gerns; Yu-Ting Chen; Linda D Hicks; Michael F Minnick; Scott E Dixon; Steven C Hall; Jane E Koehler
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

2.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

3.  Characterization of an immunogenic outer membrane autotransporter protein, Arp, of Bartonella henselae.

Authors:  Christine M Litwin; Mindy L Rawlins; Erica M Swenson
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

4.  Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.

Authors:  James R Deringer; Chen Chen; James E Samuel; Wendy C Brown
Journal:  Microbiology (Reading)       Date:  2010-10-28       Impact factor: 2.777

5.  Microarray for serotyping of Bartonella species.

Authors:  Cyrille J Bonhomme; Claude Nappez; Didier Raoult
Journal:  BMC Microbiol       Date:  2007-06-25       Impact factor: 3.605

6.  Cat-bite-induced Francisella tularensis infection with a false-positive serological reaction for Bartonella quintana.

Authors:  Evelina Petersson; Simon Athlin
Journal:  JMM Case Rep       Date:  2017-02-28

7.  Immunoproteomics Reveals Pathogen's Antigens Involved in Homo sapiens-Histoplasma capsulatum Interaction and Specific Linear B-Cell Epitopes in Histoplasmosis.

Authors:  Marcos Abreu Almeida; Rodrigo Almeida-Paes; Allan Jefferson Guimarães; Richard Hemmi Valente; Célia Maria de Almeida Soares; Rosely Maria Zancopé-Oliveira
Journal:  Front Cell Infect Microbiol       Date:  2020-10-29       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.